Literature DB >> 15733732

The role of the orphan nuclear receptor Rev-Erb alpha in adipocyte differentiation and function.

S Laitinen1, C Fontaine, J C Fruchart, B Staels.   

Abstract

Lipid and carbohydrate homeostasis in higher organisms is governed by an integrated system that has a capacity to rapidly respond to metabolic changes. Numerous signals reciprocally convey information about body fat status from the periphery to central nervous system in the attempt to maintain body weight nearly stable throughout life. The role of adipocyte in energy homeostasis extends its function as a simple energy storage cell. Indeed, adipose tissue not only secretes fatty acids, but is also an active endocrine and paracrine organ due to the production of secreted proteins and lipid indicators collectively called adipokines. These observations have spurred interest in the identification of the transcriptional and other regulatory pathways of adipocyte differentiation. The nuclear receptor, peroxisome proliferator-activated receptor gamma (PPAR gamma) (NR1C3) and members of the CCAAT enhancer-binding protein (C/EBP) family are central mediators controlling adipocyte differentiation and function. Rev-erb alpha (NR1D1) is an orphan nuclear receptor encoded on the opposite strand of the thyroid receptor alpha gene. Rev-erb alpha acts as a negative regulator of transcription binding to the same response element than another orphan nuclear receptor, ROR alpha. Rev-erb alpha is highly expressed in adipose tissue, skeletal muscle, heart, liver and brain. Rev-erb alpha expression increases during adipocyte differentiation of 3T3-L1 cells and is induced by PPAR gamma activation in both 3T3-L1 cells in vitro and in rat adipose tissue in vivo via a direct repeat (DR2) in the Rev-erb alpha promoter. Ectopic expression of Rev-erb alpha potentiates the adipocyte differentiation in 3T3-L1 cells. Recent results in vascular smooth muscle cells (VSMCs) indicate that Rev-erb alpha also controls inflammation by regulating NF-kappa B responsive genes, such as IL-6 and COX-2. Future studies on a potential role of Rev-erb alpha on glucose homeostasis and/or inflammation control are thus warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733732     DOI: 10.1016/j.biochi.2004.12.006

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  21 in total

Review 1.  Adopting new orphans into the family of metabolic regulators.

Authors:  Sarah Hummasti; Peter Tontonoz
Journal:  Mol Endocrinol       Date:  2008-02-07

2.  Bifunctional role of Rev-erbalpha in adipocyte differentiation.

Authors:  Jing Wang; Mitchell A Lazar
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

Review 3.  Energy-responsive timekeeping.

Authors:  David A Bechtold
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

4.  REV-ERB-ALPHA circadian gene variant associates with obesity in two independent populations: Mediterranean and North American.

Authors:  Marta Garaulet; Caren E Smith; Purificación Gomez-Abellán; María Ordovás-Montañés; Yu-Chi Lee; Laurence D Parnell; Donna K Arnett; José M Ordovás
Journal:  Mol Nutr Food Res       Date:  2013-10-31       Impact factor: 5.914

5.  Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erbα.

Authors:  Jennifer Jager; W Timothy O'Brien; Jessica Manlove; Elizabeth N Krizman; Bin Fang; Zachary Gerhart-Hines; Michael B Robinson; Peter S Klein; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2014-02-19

6.  Examination of nuclear receptor expression in osteoblasts reveals Rorβ as an important regulator of osteogenesis.

Authors:  Matthew M Roforth; Gang Liu; Sundeep Khosla; David G Monroe
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

7.  Crosstalk between circadian rhythmicity, mitochondrial dynamics and macrophage bactericidal activity.

Authors:  Jacqueline Oliva-Ramírez; María Maximina B Moreno-Altamirano; Benjamín Pineda-Olvera; Patricia Cauich-Sánchez; F Javier Sánchez-García
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

8.  Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.

Authors:  Xiaoming Li; Min Xu; Fei Wang; Alison B Kohan; Michael K Haas; Qing Yang; Danwen Lou; Silvana Obici; W Sean Davidson; Patrick Tso
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

Review 9.  Clocks, metabolism, and the epigenome.

Authors:  Dan Feng; Mitchell A Lazar
Journal:  Mol Cell       Date:  2012-07-27       Impact factor: 17.970

10.  Human IL10 gene repression by Rev-erbα ameliorates Mycobacterium tuberculosis clearance.

Authors:  Vemika Chandra; Sahil Mahajan; Ankita Saini; Hedwin K Dkhar; Ravikanth Nanduri; Ella B Raj; Ashwani Kumar; Pawan Gupta
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.